Samuel O'Brient

Samuel O'Brient

Expertise: Global Financial Markets, Macroeconomics and Geopolitics

Education: BA, Economics & Political Science, Sarah Lawrence College; MSc, International Politics, Trinity College Dublin

Awards & Accomplishments: Published in Curlew Quarterly. Quoted in Forbes. Interviewed by Foreign Policy.

About Samuel
Samuel O’Brient is a Reporter for InvestorPlace, where his work focuses primarily on financial markets, global economic trends, and public policy. O’Brient writes a weekly column on recent political news that investors should be following.

From his early days at InvestorPlace, O’Brient found himself drawn to the booming world of electric vehicles and green energy. His coverage of mining and other battery components has made him an expert source for industry publications. During his early years as an Economic Policy Analyst at U.S. Resist News, he gained expertise in international trade as the U.S.-China trade war dominated headlines. This in-depth research and analysis experience helped strengthen his prowess in all things political economy. O’Brient brings this expertise to work with him every day, thoughtfully analyzing how the daily happenings on the Capitol trickle down to Wall Street… and how retail investors can take action to profit.

An experienced journalist, editor, and economic policy analyst, O’Brient has spent his career guided by a deep passion for economic theory and policy. As a financial blogger on TipRanks, he has received 4.6 stars and is ranked in the top 10% of stock pickers.

O’Brient’s work on economic and tech policy has been curated by popular outlets Marker, OneZero and Gen.

He can be reached on LinkedIn and Muck Rack.

Recent Articles

NVAX Stock Shoots Higher Thanks to Global Progress on Its Covid-19 Vaccine

Novavax just got a thumbs up from Indonesia. Patient investors are hoping this means NVAX stock will be a winner in the coming year.

OCGN Stock Alert: This Covaxin Update Is Sending Ocugen Rallying

Australia just gave a vote of confidence to Covaxin, sending OCGN stock climbing. However, the real catalyst rests in the hands of the WHO.

GFAI Stock: 7 Things to Know as Little-Known Guardforce AI Rockets 80%

Guardforce AI is shooting up as social media traders take note of its new strategic partnerships. Here's what to know about GFAI stock.

XELA Stock Alert: What Is the Partnership News Taking Exela Technologies Higher?

Exela Technologies has announced a partnership with healthcare nonprofit CareSource. XELA stock is reacting well to the news.

Shiba Inu Just Overtook Dogecoin. Lesser-Known Floki Inu Thinks It Can Dethrone Both.

Shiba Inu briefly overtook Dogecoin, but the newcomer Floki Inu crypto thinks it can dethrone both for meme token dominance.